Outfitting cells in “invisibility cloaks” may offer an easier, less-damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State. The team manufactured these cloaks out of a jelly-like material known as hydrogel, which the team called biomimetic zona pellucida.
